Form 4: Zimmer Biomet Director Kolli Sreelakshmi Reports Acquisition of Phantom Stock Units

Director Kolli Sreelakshmi reported the acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Summary

• On June 30, 2024, Sreelakshmi Kolli, a director of Zimmer Biomet Holdings, Inc., acquired 144.035 phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.
• The units are convertible to common stock on a 1-for-1 basis.
• The reporting person now beneficially owns 3,772.565 shares of common stock.
• The phantom stock units will be settled in shares of company common stock within sixty days after cessation of the reporting person's service as a Director.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine transaction related to director compensation. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to director compensation and is typical for publicly traded companies. It provides transparency into the equity holdings of company insiders.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director compensation and alignment of interests.

Key Dates